Leading Academics and Industry Leaders to Keynote at DedicatedCo-Crystals Conference
September 24 - 26, 2007
Radisson SAS Hotel (Amsterdam), Amsterdam, Netherlands
LONDON, July 6, 2007--As this special issue of C&EN indicates,
the field of pharmaceutical co-crystals presents a very exciting
opportunity for the pharmaceutical industry. The promise of new
intellectual property and improved performance has created a huge
amount of interest, but many people have been struggling to find
their way in such a quickly developing area.
Now, industry is beginning to make the most of the benefits of co-crystals. And first time case studies will be presented at Pharmaceutical Co-crystals. Pharma IQ is proud to bring together the world’s leading experts in the area at this important meeting, which provides an unrivalled platform to assess the developments in the field, and understand how pharma can make the most of the potential that co-crystals can offer.
This 2007 meeting will include research updates from leading academics including Mike Zaworotko, Professor and Chairperson, Department of Chemistry, University of South Florida and Nair Rodriguez-Hornedo, Associate Professor, Department of Pharmaceutical Sciences, University of Michigan, as well as practical applications from leaders such as Scott Childs, Research Scientist, SSCI, an Aptuit Company.
Pharma IQ’s Pharmaceutical Co-Crystals 2007 is the only specific event for pharmaceutical scientists to explore the design and development of co-crystals. It will build on success of last year’s pioneering meeting, of which Ashwini Nangia of the University of Hyderabad commented “Pharma co-crystals was the most informative meeting I have attended in recent times. Great job, well done. Thank you!”
For more information about this conference, early booking discounts or to register freephone 0800 652 2363 or +44 (0)20 7368 9300, or email email@example.com.
P: +44 (0)20 7368 9306 | F: +44 (0)207 368 9303
Anchor House | 15-19 Britten Street | London SW3 3QL
Posted: July 2007